Type 2 responses at the interface between immunity and fat metabolism

Current Opinion in Immunology

Volumn 36, Issue , 2015, Pages 67-72

  Odegaard, Justin I ^a   Chawla, Ajay ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; BEIGE ADIPOSE TISSUE; BROWN ADIPOSE TISSUE; CELLULAR IMMUNITY; EOSINOPHIL; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; LIPID METABOLISM; LIPID STORAGE; LYMPHOID CELL; MACROPHAGE; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; TH2 CELL; THERMOGENESIS; TYPE 2 INNATE LIKE LYMPHOID CELL; WHITE ADIPOSE TISSUE; ADAPTIVE IMMUNITY; ANIMAL; HOMEOSTASIS; IMMUNITY; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

FAT;

ADAPTIVE IMMUNITY; ADIPOSE TISSUE; ANIMALS; FATS; HOMEOSTASIS; HUMANS; IMMUNITY; IMMUNITY, INNATE; LIPID METABOLISM; MACROPHAGES; T-LYMPHOCYTE SUBSETS;

EID: 84937428803     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2015.07.003     Document Type: Review

References (60)

1. Chovatiya R., Medzhitov R. Stress, inflammation, and defense of homeostasis. Mol Cell 2014, 54:281-288.
2. Varol C., Mildner A., Jung S. Macrophages: development and tissue specialization. Annu Rev Immunol 2015, 33:643-675.
3. de Back D.Z., Kostova E.B., van Kraaij M., van den Berg T.K., van Bruggen R. Of macrophages and red blood cells; a complex love story. Front Physiol 2014, 5:9.
4. Bilimoria P.M., Stevens B. Microglia function during brain development: new insights from animal models. Brain Res 2014.
5. Gause W.C., Wynn T.A., Allen J.E. Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. Nat Rev Immunol 2013, 13:607-614.
6. Cheng L.E., Locksley R.M. Allergic inflammation--innately homeostatic. Cold Spring Harb Perspect Biol 2015, 7:a016352.
7. Palm N.W., Rosenstein R.K., Medzhitov R. Allergic host defences. Nature 2012, 484:465-472.
8. Profet M. The function of allergy: immunological defense against toxins. Q Rev Biol 1991, 66:23-62.
9. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
10. Odegaard J.I., Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science 2013, 339:172-177.
11. Osborn O., Olefsky J.M. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 2012, 18:363-374.
12. Mathis D. Immunological goings-on in visceral adipose tissue. Cell Metab 2013, 17:851-859.
13. Brestoff J.R., Artis D. Immune regulation of metabolic homeostasis in health and disease. Cell 2015, 161:146-160.
14. Rosen E.D., Spiegelman B.M. What we talk about when we talk about fat. Cell 2014, 156:20-44.
15. Gesta S., Tseng Y.H., Kahn C.R. Developmental origin of fat: tracking obesity to its source. Cell 2007, 131:242-256.
16. Kahn B.B., Flier J.S. Obesity and insulin resistance. J Clin Invest 2000, 106:473-481.
17. Odegaard J.I., Chawla A. The immune system as a sensor of the metabolic state. Immunity 2013, 38:644-654.
18. Schwartz M.W., Seeley R.J., Tschop M.H., Woods S.C., Morton G.J., Myers M.G., D'Alessio D. Cooperation between brain and islet in glucose homeostasis and diabetes. Nature 2013, 503:59-66.
19. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
20. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830.
21. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007, 117:175-184.
22. Sun K., Kusminski C.M., Scherer P.E. Adipose tissue remodeling and obesity. J Clin Invest 2011, 121:2094-2101.
23. Sun K., Tordjman J., Clement K., Scherer P.E. Fibrosis and adipose tissue dysfunction. Cell Metab 2013, 18:470-477.
24. Kosteli A., Sugaru E., Haemmerle G., Martin J.F., Lei J., Zechner R., Ferrante A.W. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J Clin Invest 2010, 120:3466-3479.
25. Nguyen K.D., Qiu Y., Cui X., Goh Y.P., Mwangi J., David T., Mukundan L., Brombacher F., Locksley R.M., Chawla A. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 2011, 480:104-108.
26. Spits H., Artis D., Colonna M., Diefenbach A., Di Santo J.P., Eberl G., Koyasu S., Locksley R.M., McKenzie A.N., Mebius R.E., et al. Innate lymphoid cells - a proposal for uniform nomenclature. Nat Rev Immunol 2013, 13:145-149.
27. Diefenbach A., Colonna M., Koyasu S. Development, differentiation, and diversity of innate lymphoid cells. Immunity 2014, 41:354-365.
28. McKenzie A.N., Spits H., Eberl G. Innate lymphoid cells in inflammation and immunity. Immunity 2014, 41:366-374.
29. Odegaard J.I., Ricardo-Gonzalez R.R., Goforth M.H., Morel C.R., Subramanian V., Mukundan L., Eagle A.R., Vats D., Brombacher F., Ferrante A.W., et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447:1116-1120.
30. Wu D., Molofsky A.B., Liang H.E., Ricardo-Gonzalez R.R., Jouihan H.A., Bando J.K., Chawla A., Locksley R.M. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011, 332:243-247.
31. Molofsky A.B., Nussbaum J.C., Liang H.E., Van Dyken S.J., Cheng L.E., Mohapatra A., Chawla A., Locksley R.M. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Exp Med 2013, 210:535-549.
32. Lee M.W., Odegaard J.I., Mukundan L., Qiu Y., Molofsky A.B., Nussbaum J.C., Yun K., Locksley R.M., Chawla A. Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 2015, 160:74-87.
33. Hasan A., Al-Ghimlas F., Warsame S., Al-Hubail A., Ahmad R., Bennakhi A., Al-Arouj M., Behbehani K., Dehbi M., Dermime S. IL-33 is negatively associated with the BMI and confers a protective lipid/metabolic profile in non-diabetic but not diabetic subjects. BMC Immunol 2014, 15:19.
34. Brestoff J.R., Kim B.S., Saenz S.A., Stine R.R., Monticelli L.A., Sonnenberg G.F., Thome J.J., Farber D.L., Lutfy K., Seale P., et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 2014.
35. Miller A.M., Asquith D.L., Hueber A.J., Anderson L.A., Holmes W.M., McKenzie A.N., Xu D., Sattar N., McInnes I.B., Liew F.Y. Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ Res 2010, 107:650-658.
36. Cayrol C., Girard J.P. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol 2014, 31C:31-37.
37. Palmer G., Gabay C. Interleukin-33 biology with potential insights into human diseases. Nat Rev Rheumatol 2011, 7:321-329.
38. Schiering C., Krausgruber T., Chomka A., Frohlich A., Adelmann K., Wohlfert E.A., Pott J., Griseri T., Bollrath J., Hegazy A.N., et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 2014, 513:564-568.
39. Vasanthakumar A., Moro K., Xin A., Liao Y., Gloury R., Kawamoto S., Fagarasan S., Mielke L.A., Afshar-Sterle S., Masters S.L., et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat Immunol 2015, 16:276-285.
40. Cipolletta D., Feuerer M., Li A., Kamei N., Lee J., Shoelson S.E., Benoist C., Mathis D. PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012, 486:549-553.
41. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., Lee J., Goldfine A.B., Benoist C., Shoelson S., et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009, 15:930-939.
42. Kolodin D., van Panhuys N., Li C., Magnuson A.M., Cipolletta D., Miller C.M., Wagers A., Germain R.N., Benoist C., Mathis D. Antigen- and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice. Cell Metab 2015, 21:543-557.
43. Lowell B.B., Spiegelman B.M. Towards a molecular understanding of adaptive thermogenesis. Nature 2000, 404:652-660.
44. Daniel H., Derry D.M. Criteria for differentiation of brown and white fat in the rat. Can J Physiol Pharmacol 1969, 47:941-945.
45. Slavin B.G., Ballard K.W. Morphological studies on the adrenergic innervation of white adipose tissue. Anat Rec 1978, 191:377-389.
46. Trayhurn P., Ashwell M. Control of white and brown adipose tissues by the autonomic nervous system. Proc Nutr Soc 1987, 46:135-142.
47. Qiu Y., Nguyen K.D., Odegaard J.I., Cui X., Tian X., Locksley R.M., Palmiter R.D., Chawla A. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 2014, 157:1292-1308.
48. Harms M., Seale P. Brown and beige fat: development, function and therapeutic potential. Nat Med 2013, 19:1252-1263.
49. Wu J., Cohen P., Spiegelman B.M. Adaptive thermogenesis in adipocytes: Is beige the new brown?. Genes Dev 2013, 27:234-250.
50. Rao R.R., Long J.Z., White J.P., Svensson K.J., Lou J., Lokurkar I., Jedrychowski M.P., Ruas J.L., Wrann C.D., Lo J.C., et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 2014, 157:1279-1291.
51. Bhargava P., Li C., Stanya K.J., Jacobi D., Dai L., Liu S., Gangl M.R., Harn D.A., Lee C.H. Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways. Nat Med 2012, 18:1665-1672.
52. Tahapary D.L., de Ruiter K., Martin I., van Lieshout L., Guigas B., Soewondo P., Djuardi Y., Wiria A.E., Mayboroda O.A., Houwing-Duistermaat J.J., et al. Helminth infections and type 2 diabetes: a cluster-randomized placebo controlled SUGARSPIN trial in Nangapanda, Flores, Indonesia. BMC Infect Dis 2015, 15:133.
53. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., Dorfman R., Wang Y., Zielenski J., Mastronardi F., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009, 15:921-929.
54. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
55. Nishio J., Honda K. Immunoregulation by the gut microbiota. Cell Mol Life Sci 2012, 69:3635-3650.
56. Cypess A.M., Lehman S., Williams G., Tal I., Rodman D., Goldfine A.B., Kuo F.C., Palmer E.L., Tseng Y.H., Doria A., et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009, 360:1509-1517.
57. Saito M., Okamatsu-Ogura Y., Matsushita M., Watanabe K., Yoneshiro T., Nio-Kobayashi J., Iwanaga T., Miyagawa M., Kameya T., Nakada K., et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 2009, 58:1526-1531.
58. van Marken Lichtenbelt W.D., Vanhommerig J.W., Smulders N.M., Drossaerts J.M., Kemerink G.J., Bouvy N.D., Schrauwen P., Teule G.J. Cold-activated brown adipose tissue in healthy men. N Engl J Med 2009, 360:1500-1508.
59. Virtanen K.A., Lidell M.E., Orava J., Heglind M., Westergren R., Niemi T., Taittonen M., Laine J., Savisto N.J., Enerback S., et al. Functional brown adipose tissue in healthy adults. N Engl J Med 2009, 360:1518-1525.
60. Tseng Y.H., Cypess A.M., Kahn C.R. Cellular bioenergetics as a target for obesity therapy. Nat Rev Drug Discov 2010, 9:465-482.